{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:09:37Z","timestamp":1778954977922,"version":"3.51.4"},"reference-count":53,"publisher":"Informa UK Limited","issue":"15","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2023,10,13]]},"DOI":"10.1080\/14656566.2023.2244427","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:12:37Z","timestamp":1691079157000},"page":"1665-1671","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Terlipressin in the management of liver disease"],"prefix":"10.1080","volume":"24","author":[{"given":"Andrew R","family":"Scheinberg","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2988-6998","authenticated-orcid":false,"given":"Joshua A","family":"Turkeltaub","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Digestive Health and Liver Diseases, University of Miami, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"e_1_3_5_2_1","unstructured":"New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome European Medicines Agency 2022. Available from: https:\/\/www.ema.europa.eu\/en\/news\/new-recommendations-terlipressin-containing-medicines-treatment-hepatorenal-syndrome"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.08.016"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31884"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14052"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i26.3984"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000355"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221102679"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230122"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.107789"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.029"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.12.034"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28906"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27709"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0676.2000.020001051.x"},{"issue":"12","key":"e_1_3_5_17_1","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1345\/aph.1H373","article-title":"Terlipressin: vasopressin analog and novel drug for septic shock","volume":"40","author":"Pesaturo AB","year":"2006","unstructured":"Pesaturo AB, Jennings HR, Voils SA. Terlipressin: vasopressin analog and novel drug for septic shock. Ann Pharmacother. 2006 Dec 01;40(12):2170\u20132177.","journal-title":"Ann Pharmacother"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14703"},{"key":"e_1_3_5_19_1","volume-title":"Terlivaz (Terlipressin). United States Food and Drug Administration","author":"Inc. MHP","year":"2022","unstructured":"Inc. MHP. Terlivaz (Terlipressin). United States Food and Drug Administration. 2022."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2215289"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28396"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.02.014"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.026"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008290"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000861332.82608.85"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HC9.0000897228.91307.0c"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.11.020"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.01.035"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24210"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.01.012"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30208"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-023-01356-6"},{"issue":"4","key":"e_1_3_5_33_1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study","volume":"122","author":"Moreau R","year":"2002","unstructured":"Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study. Gastroenterology. 2002 Apr 01;122(4):923\u2013930.","journal-title":"Gastroenterology"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00377-6"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2012.05088.x"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840150609"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2008.147"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27006"},{"issue":"9","key":"e_1_3_5_39_1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/a-0846-3071","article-title":"Vasoactive agents for the management of variceal bleeding: a mixed treatment comparison network meta-analysis and trial sequential analysis of randomized clinical trials","volume":"69","author":"Sridharan K","year":"2019","unstructured":"Sridharan K, Sivaramakrishnan G. Vasoactive agents for the management of variceal bleeding: a mixed treatment comparison network meta-analysis and trial sequential analysis of randomized clinical trials. Drug Res (Stuttg). 2019 Aug 20;69(9):487\u2013495.","journal-title":"Drug Res (Stuttg)"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10416-6"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5106958"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21901"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.010"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.1.90"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.24800"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5049.153037"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2021.06.019"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3182120842"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.05.002"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000217"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0829-x"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13057"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619878996"},{"key":"e_1_3_5_54_1","unstructured":"Information NCfB. PubChem compound summary for CID 72081 terlipressin. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Terlipressin"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14656566.2023.2244427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T10:35:50Z","timestamp":1695638150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14656566.2023.2244427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":53,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,10,13]]}},"alternative-id":["10.1080\/14656566.2023.2244427"],"URL":"https:\/\/doi.org\/10.1080\/14656566.2023.2244427","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}